Fortrea
Bireshwar Saha is an accomplished executive with extensive experience in clinical data management and programming, currently serving as Executive Director and Global Head of CDM Programming at Fortrea since March 2019. Saha has a proven track record of building and leading diverse global teams of clinical trial professionals, emphasizing the integration of various data sources and innovative methodologies in decentralized trials. Prior to Fortrea, Saha held significant roles at IQVIA, Accenture, Quintiles, Ranbaxy Laboratories Ltd, and Torrent Pharmaceuticals Ltd, demonstrating expertise in managing large teams, executing complex clinical trials, and driving operational excellence across multiple regions. Saha holds an MBA from Duke University's Fuqua School of Business and dual master's degrees in Pharmaceutics and Pharmaceutical Sciences from the Birla Institute of Technology, Mesra.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.